| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -83.312 | 73.831 | 16.137 | 20.602 |
| Net Profit Margin | -11,367.023 | -1,242,146.174 | -95,337.094 | - |
| Debt to Asset Ratio | 45.646 | 585.939 | 577.181 | 1,071.96 |
| Cash Ratio | 185.794 | NaN | NaN | NaN |
| Quick Ratio | 214.031 | 13.947 | 17.082 | NaN |
| Current Ratio | 225.767 | 17.282 | 17.338 | 9.372 |
Aspire Biopharma Holdings, Inc. (ASBP)
Aspire Biopharma Holdings, Inc. (ASBP)